Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.

[1]  S. Yamashita,et al.  An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the “Ten Countries Study” , 2017, BMJ Open.

[2]  J. Tu,et al.  Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis , 2017, BMJ Open.

[3]  A. Hirayama,et al.  Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study , 2017, BMJ Open.

[4]  H. Daida,et al.  Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome. , 2017, International heart journal.

[5]  B. Gencer,et al.  Identifying familial hypercholesterolemia in acute coronary syndrome , 2016, Current opinion in lipidology.

[6]  L. Räber,et al.  Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes. , 2015, European heart journal.

[7]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[8]  S. Kihara,et al.  Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. , 2013, Journal of atherosclerosis and thrombosis.

[9]  S. Yamashita,et al.  Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan. , 2012, Journal of atherosclerosis and thrombosis.

[10]  G. Watts,et al.  Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. , 2012, The Journal of clinical endocrinology and metabolism.

[11]  Jennifer G. Robinson,et al.  Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[12]  M. Yamagishi,et al.  Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. , 2011, Atherosclerosis.

[13]  D. Mant.  Commentary: What's so special about familial hypercholesterolaemia? , 2009, The British journal of general practice : the journal of the Royal College of General Practitioners.

[14]  R. Rosenson,et al.  Myocardial injury: the acute phase response and lipoprotein metabolism. , 1993, Journal of the American College of Cardiology.

[15]  H. Mabuchi,et al.  Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness. , 1977, Atherosclerosis.

[16]  S. Kihara,et al.  Familial hypercholesterolemia. , 2014, Journal of atherosclerosis and thrombosis.

[17]  S. Yamashita,et al.  Guidelines for the management of familial hypercholesterolemia. , 2012, Journal of atherosclerosis and thrombosis.

[18]  H. Yazici.  Beware of registries for their biases. , 2012, Bulletin of the NYU hospital for joint diseases.